activistletters
Land & Buildings Calls on Aimco to Immediately Pursue a Full Company Sale Process and Highlights Significant Upside to Current Share Price
Applauds CEO Wes Powell and Aimco Board for $520 Million Brickell Assemblage Transaction and Expanding Ongoing Strategic Review
Believes That
activistletters
TriMas Corporation (TRS): Barington Capital Urges Strategic Alternatives Over New CEO Hire After Years of Shareholder Underperformance
Summary
Barington Capital urges TriMas to stop the CEO search and instead pursue strategic alternatives, including a sale of the
activistletters
Barington Capital Group Calls On The Board Of Directors Of Trimas Corporation To Retain A Financial Advisor To Pursue Strategic Alternatives For The Company
Mr. Herbert K. Parker
Chairman of the Board
TriMas Corporation
38505 Woodward Avenue, Suite 200
Bloomfield Hills, MI 48304
Dear
activistletters
Air Products & Chemicals (APD): Mantle Ridge Urges Shareholders to Back Director Slate, Citing Integrity Crisis, Poor Returns, and Risky Projects
Summary
Mantle Ridge criticized Air Products’ leadership under Seifi Ghasemi, accusing the company of omitting key facts, misleading shareholders about
activistletters
Mantle Ridge Issues Shareholder Letter: Restoring Integrity is Necessary for Air Products and Chemicals, Inc. to Recover and Return to Prosperity
Details Some of the Company’s Omissions, Obfuscations, and Misleading Statements Concerning Air Products’ Performance, Strategy, and Key Projects
Shareholder-Led
activistletters
Intrepid Potash (IPI): Gate City Capital Pushes for Capital Returns, Cost Cuts, and Governance Reforms After Leadership Changes
Summary
Gate City Capital (6.37% owner) urged Intrepid Potash to adopt shareholder-friendly policies, including returning 75% of free cash
activistletters
Gate City Capital Management, LLC Sent Letter To Intrepid Potash Inc.
Barth Whitham
Chairman of the Board
Intrepid Potash Inc.
707 17th Street, Suite 4200
Denver, Colorado 80202
Dear Mr. Whitham,
activistletters
Vera Bradley (VRA): Fund 1 Investments Urges Strategic Alternatives, Citing Value Destruction and Public Market Challenges
Summary
Fund 1 Investments, Vera Bradley’s largest shareholder, urged the company to explore strategic alternatives, including a sale or
activistletters
Fund 1 Investments, LLC Sent Letter To Vera Bradley, Inc.
Vera Bradley, Inc.
12420 Stonebridge Road
Roanoke, Indiana 46783
Attention: Robert Hall
cc: Board of Directors
Bob,
Fund 1 Investments
activistletters
FIGS Inc. (FIGS): Baron Capital (18% Holder) Opposes Take-Private Proposal, Urges Company to Stay Public
Summary
Baron Capital (18% owner, FIGS’ largest shareholder) opposes the December 2024 take-private proposal, arguing FIGS has a strong balance
activistletters
Bamco Inc Sent Letter To Figs, Inc.
Dear Members of the Board of Directors:
Baron Capital Group, Inc. (together with its affiliated investment vehicles, "Baron,"
activistletters
BML’s Braden Leonard Opposes Aadi Biosciences (AADI) PIPE Financing, Urges Sale or Cash Return to Shareholders
Summary
BML Investment Partners (9.9% owner) strongly opposes Aadi Bioscience’s December 19, 2024 PIPE-financed “AADI 2.0” plan,
activistletters
BML Investment Partners, L.P. Sent Letter To The Board Of Aadi Bioscience, Inc.
December 31, 2024
Board of Directors
Aadi Biosciences, Inc.
17383 Sunset Boulevard Suite A250
Pacific Palisades, CA 90272
Dear Directors,
activistletters
Fund 1 Investments Proposes Acquisition of Destination XL (DXLG), Citing Retail Strength and Liquidity Challenges
Summary
Fund 1 Investments submitted a non-binding proposal to acquire all outstanding shares of Destination XL Group (DXLG) it does
activistletters
Fund 1 Investments, LLC Delivered A Letter To Lionel F. Conacher, Chairman Of Board Of The Destination XL Group, Inc.
Dec 23, 20245 min read
Destination XL Group, Inc.
555 Turnpike Street
Canton, MA 02021
Attn: Lionel F. Conacher, Chairman
activistletters
Goodwood Inc. Targets COSCIENS Biopharma (CSCI) Over Cash Burn, Weak Strategy, and Board Accountability
Summary
Goodwood, owning 8.2% of COSCIENS, criticizes the board for burning $11.6M cash in nine months while generating
activistletters
COSCIENS Biopharma (CSCI): Goodwood Inc. Presses for Board Overhaul, Criticizes R&D Spending and Governance
COSCIENS Biopharma Inc.
222 Bay Street, Suite 3000
Toronto, ON M5K 1E7
Attn: Board of Directors
Dear Directors:
As you
activistletters
Goodwood Inc. Sent A Letter To Cosciens Biopharma Inc.
Letter Dated December 19, 2024 From Goodwood, Inc. To Cosciens Biopharma Inc.
GOODWOOD INC.
132 Trafalgar Road
Oakville, Ontario
L6J
